CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Clinical trials for CHRONIC OBSTRUCTIVE PULMONARY DISEASE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC OBSTRUCTIVE PULMONARY DISEASE trials appear
Sign up with your email to follow new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study shows trimbow inhaler helps COPD patients breathe easier in real life
Disease control CompletedThis study looked at how well the Trimbow inhaler works for people with COPD when used in real-world conditions, not just in a lab. Over 12 weeks, 362 adults aged 40 and older used the inhaler, which combines three medicines to open airways and reduce inflammation. The main goal …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated May 26, 2026 04:35 UTC
-
Home pharmacy Check-Ins may cut COPD attacks
Disease control CompletedThis study looked at whether having a pharmacist talk with patients at home after a hospital stay could reduce flare-ups of chronic obstructive pulmonary disease (COPD). 174 adults with moderate to severe COPD took part. The main goal was to count how many times patients had wors…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
New COPD inhaler shows promise in Short-Term lung function test
Disease control CompletedThis study tested three different doses of an inhaled medication called glycopyrrolate in 46 adults with COPD. Participants used the drug twice daily for one week to see if it improved their lung function compared to a placebo. The goal was to find out how well it works and if it…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE2 • Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
New program helps high-risk COPD patients take control of multiple health issues
Disease control CompletedThis study tested a program in Xishui, China, that encouraged doctors to focus on the overall health of people at high risk for COPD. Over 9,300 adults aged 35 and older with a high COPD risk score took part. The program included lung tests, health education, and help managing ot…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Peking Union Medical College • Aim: Disease control
Last updated May 26, 2026 04:33 UTC
-
Could a natural hormone help COPD patients breathe easier?
Disease control CompletedThis study tested whether a natural hormone called DHEA can help adults with COPD who also have high blood pressure in their lungs (pulmonary hypertension). 51 participants took either a low or high dose of DHEA daily for one year. The main goal was to see if DHEA improved how fa…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated May 26, 2026 04:33 UTC
-
Rural patients heal at home in landmark Hospital-at-Home trial
Disease control CompletedThis study looked at whether adults with acute illnesses like infections, heart failure, or COPD can be safely treated at home instead of in a hospital. 160 rural patients were randomly assigned to receive hospital-level care at home or usual hospital care. The goal was to see if…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 26, 2026 04:32 UTC
-
App-Based rehab helps COPD patients breathe easier longer
Disease control CompletedThis study looked at whether a mobile app can help people with COPD maintain the gains from a 4-week pulmonary rehab program. 200 patients used either the app or standard care for a year. The goal was to see if the app helped them stay active and have a better quality of life ove…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated May 26, 2026 04:30 UTC
-
New inhaler matches leading COPD treatment in lung function test
Disease control CompletedThis study tested whether a new inhaler (CHF 1535) works as well as a standard one (Symbicort) for people with chronic obstructive pulmonary disease (COPD). About 750 Chinese adults aged 40 and older with moderate-to-severe COPD took part. The main goal was to compare changes in …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated May 26, 2026 04:30 UTC
-
Real-World BREZTRI study shows symptom improvement in COPD patients
Disease control CompletedThis study followed 200 adults with moderate to severe COPD who started taking the triple-combination inhaler BREZTRI as part of their normal care. Researchers measured changes in symptoms and breathing over 24 weeks using standard questionnaires and lung function tests. The goal…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 04:30 UTC
-
Remote ventilator check keeps COPD patients out of hospital
Disease control CompletedThis study looked at whether monitoring COPD patients' home ventilators from a distance can improve how well they use the machine and reduce hospital visits. 54 adults who needed a ventilator at home were split into two groups: one received standard in-person checkups every six m…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Georg Nilius, Prof DR med • Aim: Disease control
Last updated May 26, 2026 04:29 UTC
-
New antibody shows promise in cutting COPD attacks for former smokers
Disease control CompletedThis study tested a drug called itepekimab in over 1,100 former smokers with moderate-to-severe COPD. The goal was to see if it could reduce the number of sudden worsening episodes (exacerbations) and improve breathing. Participants received either the drug or a placebo as an inj…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated May 26, 2026 04:27 UTC
-
Cholesterol drug may tame lung inflammation in COPD patients
Disease control CompletedThis study looked at whether adding a statin (a common cholesterol-lowering drug) to standard treatment can reduce airway inflammation and improve breathing in people with severe chronic obstructive pulmonary disease (COPD). Researchers measured blood markers of inflammation and …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Mohamed Salah El-Sayed • Aim: Disease control
Last updated May 26, 2026 04:27 UTC
-
New drug shows promise in cutting COPD attacks
Disease control CompletedThis study tested an experimental drug called astegolimab in over 1,300 people with chronic obstructive pulmonary disease (COPD) who had frequent flare-ups. Participants received either the drug or a placebo alongside their usual COPD treatments. The main goal was to see if asteg…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated May 26, 2026 04:27 UTC
-
New COPD combo inhaler shows promise in early trial
Disease control CompletedThis study tested a new inhaled drug combination (ensifentrine and glycopyrrolate) in 33 adults with COPD. The goal was to see how the drug moves through the body, how well it helps breathing, and if it is safe. Participants received single doses of the combination and each drug …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE2 • Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA • Aim: Disease control
Last updated May 26, 2026 03:56 UTC
-
New inhaler combo boosts exercise in COPD patients
Disease control CompletedThis study tested whether a triple-combination inhaler (BGF MDI) helps people with moderate to severe COPD breathe easier and exercise longer compared to a placebo or a dual-combination inhaler. 171 adults aged 40-80 participated. The main goal was to measure lung capacity and en…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New antibody shows promise for cutting COPD attacks in smokers
Disease control CompletedThis study tested a drug called itepekimab in over 1,200 people with moderate-to-severe COPD, a serious lung disease often caused by smoking. The goal was to see if it could reduce the number of sudden worsening episodes (exacerbations) and improve breathing. Participants were fo…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Stem cell trial for COPD shows early safety promise
Disease control CompletedThis early study tested whether a single infusion of mesenchymal stem cells is safe for people with advanced COPD. Fifteen participants received the treatment and were monitored for any immediate side effects. The goal was to see if the procedure could be tolerated without causin…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New triple inhaler shows promise for COPD patients
Disease control CompletedThis study tested whether switching from a standard two-drug inhaler to a new three-drug inhaler (CHF5993) could improve lung function in 25 people with advanced COPD. Researchers used special imaging to measure airway volume and airflow. The goal was to see if the new inhaler wa…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New drug shows promise in taming lung inflammation
Disease control CompletedThis early-stage study tested a drug called EP395 in 49 healthy adults to see if it could reduce inflammation in the lungs. Participants inhaled a substance that causes temporary airway inflammation, and researchers measured whether EP395 lowered that response compared to a place…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE1 • Sponsor: EpiEndo Pharmaceuticals • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
Could a vaccine stop lung cancer before it starts?
Prevention CompletedThis early-phase study tested a vaccine called CIMAvax-EGF in 20 people at high risk for lung cancer or survivors at risk of recurrence. The vaccine works by helping the body make antibodies against a protein that can fuel cancer growth. Researchers checked safety, immune respons…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: EARLY_PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Prevention
Last updated May 26, 2026 04:32 UTC
-
Can an online sleep program help veterans with COPD breathe and rest easier?
Symptom relief CompletedThis study tested whether an internet-based sleep treatment could improve sleep and quality of life in veterans with both COPD and insomnia. Thirteen veterans were randomly assigned to either an online behavioral sleep program or online sleep education. The goal was to see if bet…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated May 26, 2026 04:33 UTC
-
Fatigue fighter? supplements show promise for COPD patients
Symptom relief CompletedThis study looked at whether taking L-arginine and liposomal vitamin C supplements could help reduce fatigue in people with COPD and chronic respiratory failure after completing a pulmonary rehabilitation program. The study involved 101 participants aged 40 to 90. The goal was to…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Symptom relief
Last updated May 26, 2026 04:30 UTC
-
Can a smartphone app boost lung rehab for COPD patients?
Symptom relief CompletedThis study looked at whether adding a digital remote monitoring system to a standard lung rehabilitation program is practical for people with COPD. 78 participants were split into two groups: one got the standard program, and the other also used a digital device to track their he…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: University of Alberta • Aim: Symptom relief
Last updated May 26, 2026 04:29 UTC
-
Simple breathing workouts show promise for seniors with lung disease
Symptom relief CompletedThis study tested whether a set of breathing exercises and devices (PowerBreathe and Therosold PEP) could improve lung function in 60 elderly patients with COPD. Participants were split into two groups to compare different training routines. Researchers used ultrasound and breath…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Universidad Católica de Ávila • Aim: Symptom relief
Last updated May 26, 2026 04:26 UTC
-
New nasal method for COPD meds shows promise in small trial
Symptom relief CompletedThis study tested if giving a common COPD drug (salbutamol) through a special high-flow nasal device works as well as the usual mask method. 25 adults with COPD took part. The goal was to see if the nasal method could improve breathing just as much as the standard approach.
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: University Hospital, Tours • Aim: Symptom relief
Last updated May 26, 2026 03:57 UTC
-
Mindful movement may ease COPD breathlessness
Symptom relief CompletedThis study tested a gentle movement therapy called Basic Body Awareness Therapy (BBAT) as an add-on treatment for 25 people with COPD who struggle with breathlessness. BBAT focuses on balance, free breathing, and mental awareness to help patients better manage their symptoms. The…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: North District Hospital • Aim: Symptom relief
Last updated May 26, 2026 03:56 UTC
-
COPD inhaler boosts exercise capacity in new study
Symptom relief CompletedThis study looked at whether a combination inhaler (tiotropium/olodaterol) can improve exercise ability in people with COPD who have overinflated lungs. 44 adults with COPD used the inhaler for 4 weeks. Researchers measured changes in oxygen use during exercise, heart function, a…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Yonsei University • Aim: Symptom relief
Last updated May 18, 2026 12:12 UTC
-
Laughter and breathing: a new combo to fight COPD symptoms?
Symptom relief CompletedThis study looked at whether pursed lip breathing exercises and laughter therapy can reduce shortness of breath and improve daily life for people with COPD. 63 adults with COPD were split into three groups: one did breathing exercises, one did laughter therapy, and one received s…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Yuksek Ihtisas University • Aim: Symptom relief
Last updated May 18, 2026 12:02 UTC
-
Extra breathing exercises may ease COPD breathlessness
Symptom relief CompletedThis study looked at whether adding special breathing muscle training to a standard 3-week lung rehab program helps reduce shortness of breath in people with COPD. The trial included 38 patients with normal breathing strength. Researchers measured changes in how patients rated th…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: University Hospital, Brest • Aim: Symptom relief
Last updated May 14, 2026 12:03 UTC
-
New study looks under the hood of COPD drug itepekimab
Knowledge-focused CompletedThis study tested the drug itepekimab in 49 adults aged 40 to 70 with COPD who were either former or current smokers. The goal was to see how the drug works on airway inflammation, not to cure or treat the disease. Participants stayed on their usual COPD medications during the 12…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE2 • Sponsor: Sanofi • Aim: Knowledge-focused
Last updated May 26, 2026 04:36 UTC
-
ER study aims to give seriously ill patients a voice in their care
Knowledge-focused CompletedThis study tested a program called ED GOAL that helps older adults with serious illnesses like heart failure or cancer talk about their care wishes while in the emergency department. Researchers worked with 141 patients to see if the program increased how often they discussed the…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 04:32 UTC
-
VR training boosts nursing students' confidence more than traditional methods
Knowledge-focused CompletedThis study tested whether a virtual reality room (VR CAVE) could teach community nursing skills as effectively as a physical mock home. 150 final-year nursing students tried both methods. Results showed both approaches improved clinical skills equally, but students felt more sati…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: The University of Hong Kong • Aim: Knowledge-focused
Last updated May 26, 2026 04:32 UTC
-
Real-World study tracks COPD patients on triple therapy
Knowledge-focused CompletedThis study followed 250 adults with COPD in Italy who started taking the triple-combination inhaler Trixeo (budesonide/glycopyrronium/formoterol). Researchers measured how patients felt about their health after 12 weeks and up to one year of treatment. The goal was to see real-wo…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 26, 2026 04:32 UTC
-
AI predicts which patients will return to hospital
Knowledge-focused CompletedThis study looked at past patient records to see if a computer program could predict who would need to be readmitted to the hospital within 30 days of leaving. Researchers used data from 372 patients treated at home through a hospital program. The goal was to improve care, not to…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 04:31 UTC
-
Fiber study seeks clues to gut health in lung disease
Knowledge-focused CompletedThis study looked at how a short-term fiber supplement (inulin) changes gut bacteria and metabolism in people with COPD compared to healthy older and younger adults. Researchers measured fatty acid production and gut health markers from blood and stool samples. The goal was to un…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Texas A&M University • Aim: Knowledge-focused
Last updated May 26, 2026 04:31 UTC
-
Study tests amino acid drink to fight muscle loss in COPD
Knowledge-focused CompletedThis study looked at whether a special mix of essential amino acids (with extra leucine) could help elderly people with COPD build protein better than a standard amino acid supplement. Thirty-four participants received both supplements on separate days, and researchers measured h…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Texas A&M University • Aim: Knowledge-focused
Last updated May 26, 2026 04:30 UTC
-
New study aims to better time palliative care for advanced illnesses
Knowledge-focused CompletedThis study looked at 178 people with advanced cancer, chronic kidney disease, or chronic lung disease to find out when they need palliative care. Researchers used special scores to see if care was given at the right time. No extra treatments or visits were added—just observation …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS • Aim: Knowledge-focused
Last updated May 26, 2026 04:28 UTC
-
Could a simple stepper test replace fancy exercise labs for COPD patients?
Knowledge-focused CompletedThis study looked at whether a simple six-minute stepper test can give similar information as a more complex exercise test for people with COPD. The goal is to make it easier for patients to get the right exercise prescription for pulmonary rehabilitation. 65 adults with COPD par…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: ADIR Association • Aim: Knowledge-focused
Last updated May 26, 2026 04:27 UTC
-
Stepping up: new test may gauge rehab progress in lung disease
Knowledge-focused CompletedThis study looked at whether a six-minute stepper test can measure changes in exercise ability in people with COPD after a 3-week pulmonary rehabilitation program. Researchers enrolled 72 patients with all stages of COPD. The goal was to see if the number of steps taken before an…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated May 26, 2026 04:26 UTC
-
Can remote rehab work? new study puts home monitoring to the test
Knowledge-focused CompletedThis study tested whether a telerehabilitation system can reliably send health data from people with COPD at home. 40 participants used devices like pulse oximeters and activity trackers during an 8-week home exercise program. The goal was to see if the data transmitted accuratel…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: ADIR Association • Aim: Knowledge-focused
Last updated May 26, 2026 04:24 UTC
-
Hidden clots in COPD Flare-Ups: a new study reveals the numbers
Knowledge-focused CompletedThis study looked at 750 people hospitalized for a COPD flare-up to find out how many also had a blood clot in their lungs (pulmonary embolism). Doctors used a standard set of tests, including a blood test and a special CT scan, to check for clots. The goal was to learn how commo…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC
-
Massive data dive reveals COPD recovery patterns after severe attacks
Knowledge-focused CompletedThis study analyzed health records from over 3,500 people with COPD who had a severe flare-up and were then treated with a medication called BGF. Researchers tracked how often patients had another flare-up or heart-related event over time. The goal was to learn more about real-wo…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 22, 2026 13:55 UTC
-
Fish oil may help COPD patients fight muscle loss
Knowledge-focused CompletedThis study looked at whether taking fish oil supplements (EPA and DHA) for four weeks could help people with COPD build more muscle when they eat protein. 64 adults with moderate to severe COPD took part. Researchers measured muscle protein building using special isotope methods …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Texas A&M University • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC
-
Pandemic disrupted chronic disease care for nearly 1 million canadians
Knowledge-focused CompletedThis study analyzed health records from nearly 1 million Canadian adults to see how the COVID-19 pandemic affected primary care for chronic conditions like diabetes, heart failure, and depression. Researchers looked at changes in doctor visits, tests, and treatments before and du…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: McMaster University • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC
-
Smartwatch and TeleOx track COPD oxygen therapy adherence
Knowledge-focused CompletedThis study looked at how well people with severe COPD follow their prescribed long-term oxygen therapy. Researchers used a connected device called TeleOx and a smartwatch to track oxygen use and heart rate over 14-day periods. The goal was to give doctors better information betwe…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: Vivisol • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC
-
Gut chemical clues: could digestion differences explain COPD?
Knowledge-focused CompletedThis study looked at how the body handles short-chain fatty acids (SCFAs) in people with COPD compared to healthy adults. Researchers measured SCFA metabolism and body composition in 63 participants. The goal was to understand if SCFA production is lower in COPD, which could affe…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Texas A&M University • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC
-
AI predicts patient crashes before they happen
Knowledge-focused CompletedThis study looked at data from 526 patients treated at home through a hospital-at-home program. Researchers used a computer algorithm to try to predict if a patient would get worse during their stay. The goal was to see if machine learning could help doctors spot problems earlier…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC
-
Can a smartphone app help manage chronic disease? study finds out.
Knowledge-focused CompletedThis study tested how easy and acceptable the P-STEP mobile app is for people with chronic conditions like asthma, COPD, heart disease, or type 2 diabetes. 178 adults in Leicester, UK, used the app for 12 weeks and gave feedback on its usability. The goal was to see if the app is…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: University of Leicester • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC
-
COPD Patients' lungs leak more during exercise, study finds
Knowledge-focused CompletedThis study looked at whether people with COPD have more leakage in their lung blood vessels during exercise, which might cause shortness of breath. Researchers compared 32 participants (COPD patients and healthy controls) by measuring lung changes before and after exercise. The g…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC
-
COPD study seeks to personalize exercise tracking
Knowledge-focused CompletedThis study looked at how people with COPD experience physical activity. Researchers interviewed 54 participants and used activity monitors to compare standard intensity measures with personalized ones. The goal was to better understand what physical activity means to patients and…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: University of Leicester • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC
-
Inhaler testers put to the test in COPD study
Knowledge-focused CompletedThis study looked at whether three different inhaler testers (Accuhaler, Ellipta, and Turbutester) can accurately measure how hard COPD patients can breathe in. 82 adults with COPD used the testers, and the results were compared to a standard device. The goal was to see if these …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: Thammasat University • Aim: Knowledge-focused
Last updated May 20, 2026 11:53 UTC
-
New PET technique could sharpen lung cancer detection
Knowledge-focused CompletedThis study tested a special breathing-synchronized PET scan method to get clearer images of small lung nodules. 103 adults with lung nodules (from cancer or COPD) had a standard PET scan plus an extra 10-minute gated scan. The goal was to see if the new method reduces motion blur…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated May 20, 2026 11:53 UTC
-
Lung clearance study reveals ventilation secrets in COPD and healthy lungs
Knowledge-focused CompletedThis study looked at how a breathing technique called ELTGOL affects air distribution in the lungs of people with COPD and healthy volunteers. Participants lay on their side while researchers applied gentle pressure to the chest and abdomen. The goal was to understand how these p…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: William Poncin, PT, PhD • Aim: Knowledge-focused
Last updated May 18, 2026 12:12 UTC
-
New COPD drug candidate tested for safety in healthy volunteers
Knowledge-focused CompletedThis early-stage trial tested the safety of Hemay005 tablets in 468 healthy Chinese adults. Researchers compared different ways of giving the drug (gradually increasing the dose vs. fixed dose) to see which caused fewer side effects. The goal was to gather safety information befo…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE1 • Sponsor: Anhui Hemay Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated May 18, 2026 12:10 UTC
-
Fungus in lungs linked to COPD symptoms
Knowledge-focused CompletedThis study looked at 100 people with advanced COPD to see if the presence of aspergillus fungus in their sputum is linked to worse quality of life and breathing problems. Participants provided sputum samples and filled out questionnaires at the start, then again by phone after 1 …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated May 18, 2026 12:02 UTC
-
Can a simple questionnaire bring better spiritual care to the dying?
Knowledge-focused CompletedThis study involved 100 patients with serious illnesses like cancer, heart failure, COPD, or ALS who were receiving palliative care. Researchers used a questionnaire to find out patients' spiritual needs and then provided specialized spiritual care to address them. The goal was t…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: University Hospital Muenster • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC
-
Study aims to ease COPD treatment burden for cancer patients
Knowledge-focused CompletedThis study gathered information from 101 patients and healthcare providers to design a care pathway for COPD in people with lung or head and neck cancer. The goal was to reduce treatment burden and overcome common barriers to COPD care in community oncology clinics. Researchers u…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC